Cadila Healthcare Moraiya plant gets USFDA warning letter for significant violations of CGMP Medical Dialogues Bureau16 Nov 2019 5:41 AM GMTCadila Healthcare failed to clean, maintain, and, as appropriate for the nature of the drug, sanitize and/or sterilise equipment and utensils at...
Zydus Cadila receives warning letter from USFDA for Moraiya-based formulation facility Medical Dialogues Bureau5 Nov 2019 7:27 AM GMTNew Delhi: Drug firm Zydus Cadila on Monday said it has received a warning letter from the US health regulator for its Moraiya-based formulation...
Emcure Pharma gets USFDA Warning Letter for Manufacturing Violations at Pune plant Medical Dialogues Bureau16 Aug 2019 4:15 AM GMTIn the letter, the USFDA said inspectors during February 11-20 this year found significant deviations from standard manufacturing practices at Emcure...
USFDA issues warning letter to Indoco Remedies for Goa plant Medical Dialogues Bureau16 July 2019 6:09 AM GMTThe facility had received six observations in Form 483s and was classified as Official Action Indicated in March. Indoco Remedies responded to these...
FDA warns companies for promoting alternatives to street drugs Ruby Khatun Khatun18 Dec 2017 4:59 AM GMTThe U.S. Food and Drug Administration (FDA) posted a warning letter to the marketers and distributors of Legal Lean Syrup, a drink, and Coco Loko, a...
Securities class action lawsuit served on Dr Reddys in US Ruby Khatun Khatun1 Dec 2017 5:11 AM GMTNew Delhi: Drug firm Dr. Reddy's Laboratories on Wednesday said it has been served a securities class action lawsuit in the US for alleged violations...
Lupin gets warning letter from USFDA for Goa, Indore plants Ruby Khatun Khatun17 Nov 2017 5:30 AM GMTNew Delhi: The US Food and Drug Administration (USFDA) has issued a warning letter to Lupin for violation of current good manufacturing practice norms...
Divis Labs gets 6 USFDA observations for Vizag unit Ruby Khatun Khatun21 Sep 2017 4:57 AM GMTNew Delhi: Drug firm Divis Laboratories on Thursday said it has received six new observations from the US Food and Drug Administration (USFDA) after...
